Literature DB >> 22852466

Efficient siRNA delivery system using carboxilated single-wall carbon nanotubes in cancer treatment.

Ioana Berindan Neagoe1, Cornelia Braicu, Cristian Matea, Constantin Bele, Graur Florin, Katona Gabriel, Chedea Veronica, Alexandru Irimie.   

Abstract

Several functionalized carbon nanotubes have been designed and tested for the purpose of nucleic acid delivery. In this study, the capacity of SWNTC-COOH for siRNA deliverey were investigated delivery in parallel with an efficient commercial system. Hep2G cells were reverse-transfected with 50 nM siRNA (p53 siRNA, TNF-alphasiRNA, VEGFsiRNA) using the siPORT NeoFX (Ambion) transfection agent in paralel with SWNTC-COOH, functionalised with siRNA. The highest level of gene inhibition was observed in the cases treated with p53 siRNA gene; in the case of transfection with siPort, the NeoFX value was 33.8%, while in the case of SWNTC-COOH as delivery system for p53 siRNA was 37.5%. The gene silencing capacity for VEGF was 53.7%, respectively for TNF-alpha 56.7% for siPORT NeoFX delivery systems versus 47.7% (VEGF) and 46.5% (TNF-alpha) for SWNTC-COOH delivery system. SWNTC-COOH we have been showed to have to be an efficient carrier system. The results from the inhibition of gene expresion for both transfection systems were confirmed at protein level. Overall, the lowest mRNA expression was confirmed at protein level, especially in the case of p53 siRNA and TNF-alpha siRNA transfection. Less efficient reduction protein expressions were observed in the case of VEGF siRNA, for both transfection systems at 24 h; only at 48 h, there was a statistically significant reduction of VEGF protein expression. SWCNT-COOH determined an efficient delivery of siRNA. SWNTC-COOH, combined with suitable tumor markers like p53 siRNA, TNFalpha siRNA or VEGF siRNA can be used for the efficient delivery of siRNA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22852466     DOI: 10.1166/jbn.2012.1411

Source DB:  PubMed          Journal:  J Biomed Nanotechnol        ISSN: 1550-7033            Impact factor:   4.099


  5 in total

Review 1.  RNA interference: new mechanistic and biochemical insights with application in oral cancer therapy.

Authors:  Smaranda Buduru; Alina-Andreea Zimta; Cristina Ciocan; Cornelia Braicu; Diana Dudea; Alexandra Iulia Irimie; Ioana Berindan-Neagoe
Journal:  Int J Nanomedicine       Date:  2018-06-08

2.  Photoactivatable nanoCRISPR/Cas9 System Based on crRNA Reversibly Immobilized on Carbon Nanoparticles.

Authors:  Olga Semikolenova; Lubov Sakovina; Elizaveta Akhmetova; Daria Kim; Ivan Vokhtantsev; Victor Golyshev; Mariya Vorobyeva; Sergey Novopashin; Darya Novopashina
Journal:  Int J Mol Sci       Date:  2021-10-09       Impact factor: 5.923

3.  Non-Viral Delivery and Therapeutic Application of Small Interfering RNAs.

Authors:  N A Nikitenko; V S Prassolov
Journal:  Acta Naturae       Date:  2013-07       Impact factor: 1.845

Review 4.  Nanopharmacology in translational hematology and oncology.

Authors:  Ciprian Tomuleasa; Cornelia Braicu; Alexandra Irimie; Lucian Craciun; Ioana Berindan-Neagoe
Journal:  Int J Nanomedicine       Date:  2014-07-22

Review 5.  Future trends and emerging issues for nanodelivery systems in oral and oropharyngeal cancer.

Authors:  Alexandra Iulia Irimie; Laura Sonea; Ancuta Jurj; Nikolay Mehterov; Alina Andreea Zimta; Liviuta Budisan; Cornelia Braicu; Ioana Berindan-Neagoe
Journal:  Int J Nanomedicine       Date:  2017-06-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.